Overview

A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to verify the non-inferiority of TAU-284 to ketotifen fumarate dry syrup in the change in the severity of pruritus after the treatment period.
Phase:
Phase 3
Details
Lead Sponsor:
Mitsubishi Tanabe Pharma Corporation
Treatments:
Bepotastine besilate
Ketotifen